Core Insights - Ecolab reported $4.17 billion in revenue for Q3 2025, a year-over-year increase of 4.2%, with an EPS of $2.07 compared to $1.83 a year ago, exceeding both revenue and EPS consensus estimates [1][2] Financial Performance - Revenue of $4.17 billion surpassed the Zacks Consensus Estimate of $4.12 billion by +1.05% [1] - EPS of $2.07 exceeded the consensus estimate of $2.06 by +0.49% [1] Segment Performance - Global Pest Elimination (Fixed Currency): $322.6 million, +4.5% year-over-year, above the estimate of $320.81 million [4] - Global Water (Fixed Currency): $1.95 billion, -2% year-over-year, slightly above the estimate of $1.94 billion [4] - Global Life Sciences (Fixed Currency): $171 million, above the estimate of $168.71 million [4] - Global Institutional & Specialty (Fixed Currency): $1.54 billion, +10.1% year-over-year, below the estimate of $1.56 billion [4] - Global Life Sciences (Public Currency): $184.7 million, above the estimate of $179.65 million [4] - Global Pest Elimination (Public Currency): $331.8 million, +8% year-over-year, slightly below the estimate of $333.75 million [4] - Global Institutional & Specialty (Public Currency): $1.59 billion, +14.3% year-over-year, above the estimate of $1.58 billion [4] - Global Water (Public Currency): $2.05 billion, +4.5% year-over-year, slightly below the estimate of $2.06 billion [4] Operating Income - Global Life Sciences (Fixed Currency): $28.1 million, above the estimate of $27.45 million [4] - Global Pest Elimination (Fixed Currency): $67.4 million, above the estimate of $64.63 million [4] - Global Institutional & Specialty (Fixed Currency): $365 million, below the estimate of $375.71 million [4] - Corporate (Fixed Currency): -$73.7 million, worse than the estimate of -$48.73 million [4] Stock Performance - Ecolab shares returned +2.5% over the past month, compared to the Zacks S&P 500 composite's +3.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market [3]

Core Insights - Ecolab, Inc. (ECL) is set to report its third-quarter 2025 results on October 28, with adjusted EPS expectations of $2.06, reflecting a 12.6% year-over-year growth [1][14]. Ecolab's Global Water Segment - The Global Industrial segment has been renamed Global Water, which includes Light & Heavy, Food & Beverage, and Paper, showing sales growth driven by Food & Beverage and Light & Heavy [3][4]. - The Zacks Consensus Estimate for Global Water revenues in Q3 2025 is $1.94 billion, indicating continued momentum from previous quarters [7]. Ecolab's Global Pest Elimination Segment - The Global Pest Elimination segment experienced organic growth and benefits from acquisitions, with Q3 2025 revenue estimates at $321 million, a 3.9% increase from the previous year [8][10]. - The company is focusing on Pest Intelligence, which involves remote monitoring, and is strengthening its B2B business in the U.S. and select countries [9]. Other Business Segments - The Global Institutional & Specialty segment is integrating its units, with strong sales growth expected to continue [12]. - Despite facing challenges in Paper sales and basic industries, the company is overcoming these through strategic exits from low-margin businesses [13]. Financial Performance and Valuation - Total revenue for Q3 2025 is estimated at $4.12 billion, a 3.1% increase from the prior year [14]. - Ecolab's forward P/E ratio is 33.1X, higher than the industry average of 21.8X, indicating a premium valuation compared to peers [20][21]. Long-Term Growth Prospects - Ecolab is making strides in its Global Water business through acquisitions, enhancing its capabilities in water safety and digital monitoring [22][25]. - The Global Life Sciences segment is expected to grow significantly, particularly in the biologics drug market, with double-digit growth anticipated [26].

Core Insights - Ecolab reported $4.03 billion in revenue for Q2 2025, a 1% year-over-year increase, with an EPS of $1.89 compared to $1.68 a year ago [1] - The revenue exceeded the Zacks Consensus Estimate of $4.01 billion by 0.42%, while the EPS fell short of the consensus estimate of $1.90 by 0.53% [1] Financial Performance Metrics - Global Pest Elimination sales were $311.3 million, slightly above the estimated $309.06 million [4] - Global Water sales were $1.91 billion, below the estimated $1.92 billion, reflecting a 2.4% decrease year-over-year [4] - Global Life Sciences sales were $176.7 million, below the estimated $179.14 million [4] - Global Institutional & Specialty sales reached $1.51 billion, slightly below the estimated $1.53 billion, but showed a 10.1% year-over-year increase [4] - Operating Income for Global Life Sciences was $34.8 million, exceeding the estimate of $27.2 million [4] - Operating Income for Global Pest Elimination was $61.2 million, slightly above the estimated $60.41 million [4] - Corporate Operating Income was reported at -$75 million, worse than the estimated -$48.9 million [4] Stock Performance - Ecolab's shares returned +0.2% over the past month, underperforming the Zacks S&P 500 composite's +3.6% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3]